Overview

Bioequivalence Study Coadministered to Healthy Subjects in the Fasted State

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate bioequivalence of coadministered drugs on healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Dapagliflozin
Saxagliptin